Medical device companies face an expanding set of legal and regulatory requirements to address risks and concerns around product safety. As product safety requirements increase, device companies must expand their approach to both post-market safety surveillance and managing product risks.

In their article, Post-Market Safety Surveillance, published this month in MD&DI (Medical Device and Diagnostic Industry), NAI Consultant Stephen Rothenberg, J.D., and Business Analyst Matt Levy, J.D., explain what’s driving the growing push for increased post-market safety surveillance, and how medical device companies can meet these demands.